E.L. van der Veen

E-mail:
e.l.van.der.veen umcg.nl

Research

Publications
  1. First-in-human PET imaging with the PD-L1 antibody Zr-89-atezolizumab

    Bensch, F., van der Veen, E., Jorritsma, A., Lub-de Hooge, M., Boellaard, R., Oosting, S., Schroder, C., Hiltermann, J., van der Wekken, A., Groen, H., Fine, B., McKnight, N., Bohorquez, S. S., Williams, S., Veronese, L., Mancao, C., Brouwers, A. H. & de Vries, E., Jul-2017, In : Cancer Research. 77, 2 p.

    Research output: Contribution to journalMeeting AbstractAcademic

  2. Implementing [F-18]FB-IL2 synthesis in GMP

    Hessels-Scheper, J. G., Maarsingh, P., van der Veen, E. L., Antunes, I. F., Zijlma, R., Boersma, H. H., Luurtsema, G., Elsinga, P. H. & de Vries, E. F. J., Oct-2017, In : European Journal of Nuclear Medicine and Molecular Imaging. 44, p. S527-S528 2 p.

    Research output: Contribution to journalMeeting AbstractAcademic

  3. Zr-89-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer

    Bensch, F., van der Veen, E. L., Lub-de Hooge, M. N., Jorritsma-Smit, A., Boellaard, R., Kok, I. C., Oosting, S. F., Schroder, C. P., Hiltermann, T. J. N., van der Wekken, A. J., Groen, H. J. M., Kwee, T. C., Elias, S. G., Gietema, J. A., Bohorquez, S. S., de Crespigny, A., Williams, S-P., Mancao, C., Brouwers, A. H., Fine, B. M. & de Vries, E. G. E., Dec-2018, In : Nature Medicine. 24, 12, p. 1852-1858 7 p.

    Research output: Contribution to journalLetterAcademicpeer-review

  4. Molecular imaging to enlighten cancer immunotherapies and underlying involved processes

    van der Veen, E. L., Bensch, F., Glaudemans, A. W. J. M., Lub-de Hooge, M. N. & de Vries, E. G. E., Nov-2018, In : CANCER TREATMENT REVIEWS. 70, p. 232-244 13 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

View all (6) »

View graph of relations

ID: 329108